 | Marker Therapeutics, Inc. | |||
| NCM : MRKR || Location: United States | ||||
$4.1-0.21 (-4.87%) |
0.01 M | 4.09 - 4.4 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 0.108 M |
| March 15, 2024 | 0.150 M |
| Feb. 29, 2024 | 0.161 M |
| Feb. 15, 2024 | 0.178 M |
| Jan. 31, 2024 | 0.176 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2022 | -1.02 | -0.48 | 52.94% |
| 09/30/2022 | -1.22 | -0.80 | 34.64% |
| 06/30/2022 | -1.29 | -1.10 | 14.86% |
| 03/31/2022 | -1.36 | -1.20 | 11.76% |
| 12/31/2021 | -1.27 | -1.20 | 5.50% |
MRKR Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 8.903M | Shares Float | 6.747M |
| Short Float | 0.108M | Market Cap | 38.37M |
| Institution ownership | 22.95% | Insider ownership | 12.167% |
| Earnings Date | 05/13/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -1.59 | Forward EPS | -3.40 |